Endometrioid Ovarian Cancer clinical trials

Explore recruiting endometrioid ovarian cancer clinical trials.

Recruiting endometrioid ovarian cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Endometrioid Ovarian Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ALEPRO: abemaciclib and letrozole in estrogen receptor positive rare ovarian cancer

Belgium, France, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase Ib/ IIa, open-label, dose finding, safety, tolerability and exploratory study of THEO-260 in patients with high grade serous or endometrioid ovarian cancer

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Endometrioid Ovarian Cancer trials by city

Endometrioid Ovarian Cancer clinical trials

Recruiting endometrioid ovarian cancer studies right now

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Trial of THEO-260 in Ovarian Cancer Patients

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

Study of NTB-928 in R/R OC

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Also recruiting in Europe

ALEPRO: abemaciclib and letrozole in estrogen receptor positive rare ovarian cancer

A Phase Ib/ IIa, open-label, dose finding, safety, tolerability and exploratory study of THEO-260 in patients with high grade serous or endometrioid ovarian cancer

Endometrioid Ovarian Cancer trials by city

Other conditions